Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-014364
Filing Date
2025-05-14
Accepted
2025-05-14 19:40:18
Documents
1
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6668
  Complete submission text file 0001127602-25-014364.txt   8060
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Issuer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
HENDERSON JOHN T (Reporting) CIK: 0001226488 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50633 | Film No.: 25947863